Trial Profile
Phase I neutralization study of EP 217609 and its antidote avidin in volunteers.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 05 Nov 2016
Price :
$35
*
At a glance
- Drugs Avidin (Primary) ; EP 217609 (Primary)
- Indications Thrombosis
- Focus Adverse reactions; Therapeutic Use
- 15 Oct 2016 Results published in the European Journal of Clinical Pharmacology
- 07 Mar 2011 New trial record